secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001356576-26-000015
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus to report Q1 2026 results on May 5, 2026 after market close
--------------------------------------------------------------------

- Results announced after close May 5, 2026; conference call at 4:30 PM ET.
- Call hosted by CEO Jack Khattar and CFO Tim Dec; Q&A session to follow.
- Live webcast accessible via supernus.com/investors; replay available for 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000015/0001356576-26-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000015/supn-20260422.htm
  HTML page:      https://secwatch.observer/filing/0001356576-26-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer